Sophie Richard

Sophie Richard

Auto-generated profile, based on publicly available information

Sophie Richard

Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057, CNRS and Université Paris Diderot, 75205 Paris CEDEX 05, France

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
VDVicard Du
Vicard Du
NLNathalie Luciani
Nathalie Luciani
SRSophie Richard
Sophie Richard
GMGaëtan Mary
Gaëtan Mary
CGCyprien Gay
Cyprien Gay
Claire WilhelmClaire Wilhelm
Claire Wilhelm
The ability to create a 3D tissue structure from individual cells and then to stimulate it at will is a major goal for both the biophysics and regenerative medicine communities. Here we show an integrated set of magnetic techniques that meet this challenge using embryonic stem cells (ESCs). We assessed the impact of magnetic nanoparticles internalization on ESCs viability, proliferation, pluripotency and differentiation profiles. We developed magnetic attractors capable of aggregating the cells remotely into a 3D embryoid body. This magnetic approach to embryoid body formation has no discernible impact on ESC differentiation pathways, as compared to the hanging drop method. It is also the base of the final magnetic device, composed of opposing magnetic attractors in order to form embryoid bodies in situ, then stretch them, and mechanically stimulate them at will. These stretched and cyclic purely mechanical stimulations were sufficient to drive ESCs differentiation towards the mesodermal cardiac pathway.

20 March 2015 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
ETEliott Teston
Eliott Teston
SRSophie Richard
Sophie Richard
TMThomas Maldiney
Thomas Maldiney
NLNicole Lièvre
Nicole Lièvre
GWGuillaume Yangshu Wang
Guillaume Yangshu Wang
YLYoann Lalatonne
Yoann Lalatonne

1 June 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
SRSophie Richard
Sophie Richard
MBMarianne Boucher
Marianne Boucher
YLYoann Lalatonne
Yoann Lalatonne
SMSébastien Mériaux
Sébastien Mériaux
LMLaurence Motte
Laurence Motte

31 August 2016 in ACS Chemical Biology
Verified
Journal Article
Closed access
SRSophie Richard
Sophie Richard
ASAna Saric
Ana Saric
MBMarianne Boucher
Marianne Boucher
CSChristian Slomianny
Christian Slomianny
FGFrançoise Geffroy
Françoise Geffroy
LMLaurence Motte
Laurence Motte

15 July 2025 in Nanoscale
Verified
Journal Article
Closed access
PDF file
MBMarie Bolon
Marie Bolon
MFMaxime Fieux
Maxime Fieux
CMClaire Monge
Claire Monge
SRSophie Richard
Sophie Richard
Brain disorders affect over one billion people globally, presenting significant challenges for effective treatment due to the limited drug bioavailability in the brain. The graphical abstract was created with BioRender.

14 October 2016 in Nanomedicine
Verified
Journal Article
Closed access
SRSophie Richard
Sophie Richard
VEVéronique Eder
Véronique Eder
GCGianvito Caputo
Gianvito Caputo
CJClément Journé
Clément Journé
POPhalla Ou
Phalla Ou
YLYoann Lalatonne
Yoann Lalatonne
Aim: Tunable size ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles from 3 to 9 nm coated with polyethylene glycol phosphonate moieties have been designed for neovascularization MRI. Materials & methods: USPIO were synthesized using a nonaqueous sol-gel method. An ischemia-reperfusion rat model has been chosen for neo-angiogenesis and scanned on MRI after injection of different sized USPIO. Histological studies have been performed for USPIO localization within the tissue. Results: The magnetic properties and consequently their MRI relaxivities are drastically dependent on the crystalline core size. In vivo MRI spots were observed specifically in the ischemic area. The best MRI contrast within neovascularization is generated by 6 nm nanoparticles proving that compromise between T2 relaxivity and physico-chemical properties is essential for the design of effective MRI contrast agent.